MoonLake Immunotherapeutics MLTX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $334.52M+85.4% | $180.43M-60.0% | $451.17M+1,042% | $39.51M+391% | ||
| $59.45M-77.8% | $267.6M+347% | $59.84M+83.5% | $32.61M— | ||
| $421.69M-11.1% | $474.29M-7.8% | $514.17M+572% | $76.51M+694% | ||
| $577K-20.1% | $722K+125% | $320.87K+550% | $49.39K+8.0% | ||
| $2.74M-24.8% | $3.64M-70.5% | $12.37M+3,627% | $331.97K+626% | ||
| $424.43M-11.2% | $477.93M-9.2% | $526.54M+585% | $76.84M+694% | ||
| $45.48M+102% | $22.46M+125% | $9.97M+30.0% | $7.67M-63.6% | ||
| $74.1M— | $0— | —— | —— | ||
| $74.47M+3,482% | $2.08M-32.6% | $3.08M+650% | $411.16K+71.4% | ||
| $119.95M+389% | $24.54M+88.1% | $13.05M+61.6% | $8.08M-62.1% | ||
| -$462.91M-96.5% | -$235.59M-102% | -$116.66M-44.6% | -$80.65M-50.3% | ||
| $304.48M-31.9% | $446.83M-9.9% | $495.68M+914% | $48.9M+520% | ||
| $424.43M-11.2% | $477.93M-9.2% | $526.54M+585% | $76.84M+694% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MoonLake Immunotherapeutics's total assets?
- MoonLake Immunotherapeutics (MLTX) holds $400.4M in total assets, down 21.7% year over year.
- How much debt does MoonLake Immunotherapeutics have?
- MoonLake Immunotherapeutics carries $100.8M in total debt against $254.0M of shareholders' equity, a debt-to-equity ratio of 0.40.
- How much cash does MoonLake Immunotherapeutics have?
- MoonLake Immunotherapeutics holds $298.5M in cash and equivalents.
- Can MoonLake Immunotherapeutics cover its short-term obligations?
- Its current ratio is 8.60 — current assets exceed current liabilities.
- Where does MoonLake Immunotherapeutics's balance sheet data come from?
- Every line is extracted from MoonLake Immunotherapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.